D81.82 - Activated Phosphoinositide 3-kinase Delta Syndrome [APDS]
- Applicable to Activated Phosphoinositide 3-kinase Delta Syndrome [APDS]
- The 2025 edition of ICD10-CM D81.82 became effective on October 1, 2024.
- This is the American ICD10-CM version of D81.82 - other international versions of ICD10 D81.82 may differ.
- D81.82 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- p110d-activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency [PASLI] disease
codeAlso
- , if applicable, any associated manifestations, such as:
- bronchiectasis (J47.-)
- herpes virus infections (B00.-)
- other acute respiratory tract infections (J00-J06; J20-J22)
- other infections (A00-B99)
- pneumonia (J12-J18)
Billable/Specific Code
The following codes above D81.82 contain annotation back-references that may be applicable to D81.82:
- Chapter: D50-D89 - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Section: D80-D89 - Certain disorders involving the immune mechanism
- Category: D81 - Combined immunodeficiencies
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com